Compare DLY & OMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DLY | OMDA |
|---|---|---|
| Founded | 2019 | 2011 |
| Country | United States | United States |
| Employees | N/A | 868 |
| Industry | Investment Managers | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 681.0M | 711.1M |
| IPO Year | N/A | N/A |
| Metric | DLY | OMDA |
|---|---|---|
| Price | $14.16 | $12.55 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $24.00 |
| AVG Volume (30 Days) | 251.3K | ★ 1.1M |
| Earning Date | 01-01-0001 | 05-17-2026 |
| Dividend Yield | ★ 8.93% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $24.94 |
| Revenue Next Year | N/A | $20.18 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.51 | $10.28 |
| 52 Week High | $15.80 | $26.92 |
| Indicator | DLY | OMDA |
|---|---|---|
| Relative Strength Index (RSI) | 53.86 | 44.58 |
| Support Level | $13.89 | $10.28 |
| Resistance Level | $14.86 | $16.93 |
| Average True Range (ATR) | 0.19 | 0.77 |
| MACD | 0.07 | -0.09 |
| Stochastic Oscillator | 87.33 | 32.28 |
DoubleLine Yield Opportunities Fund is a diversified, limited-term, closed-end management investment company. Its investment objective is to seek a high level of total return, with an emphasis on current income. The company invests in debt securities and other income-producing investments of issuers anywhere in the world, including in emerging markets, and may invest in investments of any credit quality. Its investment portfolio comprises foreign corporate bonds, foreign government bonds, non-agency commercial mortgage-backed obligations, U.S. corporate bonds, collateralized loan obligations, and bank loans among other securities.
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.